A Comparative Study of the Use of Navoban (ICS 205-930), a 5-HT3 Antagonist, versus a Standard Antiemetic Regimen of Dexamethasone and Metoclopramide in the Treatment of Cisplatin-Containing Chemotherapy
2001 ◽
Vol 268
(6)
◽
pp. 1739-1748
2001 ◽
Vol 48
(2)
◽
pp. 97-106
◽